Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome
Matthew B. Yurgelun(Dana-Farber Brigham Cancer Center), Elena M. Stoffel(University of Michigan), Amie Blanco(University of California, San Francisco), Rowena Mercado(Dana-Farber Cancer Institute), Peggy Conrad(University of California, San Francisco), Kristen M. Shannon(Massachusetts General Hospital), Monica Dandapani(Dana-Farber Cancer Institute), Margery Rosenblatt(Dana-Farber Cancer Institute), Wendy Kohlmann(University of Utah), Stephen B. Gruber(University of Southern California), Sapna Syngal(Dana-Farber Cancer Institute), Daniel C. Chung(Icahn School of Medicine at Mount Sinai), Jonathan P. Terdiman(UCSF Helen Diller Family Comprehensive Cancer Center), Judy E. Garber(Dana-Farber Cancer Institute)
Cited by 23
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k